Kindred Healthcare set to become a powerhouse - Barron's
NEW YORK May 1 (Reuters) - The recent whipsaw of Kindred Healthcare (KND.N) shares and the uncertainty surrounding Medicare rate cuts should not deter investors, according to a report in the May 2 edition of Barron's.
Instead, they should keep an eye on Kindred's strong points which includes a pending $1.3 billion acquisition of rival RehabCare Group RHB.N, the report said.
Kindred Healthcare Chief Executive Paul Diaz told Barron's the transaction will create the largest post-acute-care hospital company in the U.S.
Some bullish analysts think the stock could move into the mid-$30s within a year, the report said.
Shares of Kindred closed at $25.22 on Friday.
- U.S.-Israeli tensions rise as hostilities in Gaza subside |
- Hague court to order Russia to pay $50 billion in Yukos case: paper
- Pushing locals aside, Russians take top rebel posts in east Ukraine
- Obama could curb corporate 'inversions' on his own: ex-U.S. official
- Family of five found shot dead in Maine home: police